BROADCASTS.com

CardioNerds\xa0(Amit Goyal,\xa0Daniel Ambinder) and Dr. Mark Belkin, (CardioNerds Correspondent) and Dr. Shirlene Obuobi (CardioNerds Ambassador) from University of Chicago are honored to bring to you the Dr. Milton Packer perspective on the evolution of the neurohormonal hypothesis as part of The CardioNerds Heart Success Series. \n\n\n\nIn part 4, Dr. Packer shares his perspective on the revolutionary SGLT2 inhibors. We discuss the mechanisms of action and the data regarding their role in the care of heart failure patients. This episode is particularly historic in that Dr. Packer shares his thoughts about the EMPEROR-PRESERVED trial well before the data was available. Also see Dr. Mark Belkin's DocWire News article EMPEROR\u2019s New Groove? Empagliflozin Provides Long-Awaited Treatment for HFpEF where Dr. Packer is quoted as saying \u201cwe are pleased to have the first trial in patients with HFpEF that shows an unequivocally positive and clinically important result.\xa0We are looking forward to many secondary papers that will provide detailed information about what we have found, and what it means for patients.\u201d \n\n\n\nCheck out the\xa0CardioNerds\xa0Heart Failure Success Series Page\xa0for more heart success episodes and content!\n\n\n\nThis is a non CME episode. Disclosures: Milton Packer reports receiving consulting fees from\xa0Abbvie, Actavis,\xa0Amgen, Amarin,\xa0AstraZeneca,\xa0Boehringer Ingelheim,\xa0Bristol Myers Squibb, Casana, CSL Behring,\xa0Cytokinetics,\xa0Johnson & Johnson Health Care Systems Inc., Eli Lilly and Company,\xa0Moderna, Novartis, ParatusRx, Pfizer, Relypsa, Salamandra, Synthetic Biologics,\xa0Teva Pharmaceuticals USA Inc.\xa0and Theravance Biopharma Inc.\n\n\n\n\n\n\n\n\n\nCardioNerds\xa0Heart Failure Success Series PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll\n\n\n\n\n\nCardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron!\n\n\n\n\n\nThis CardioNerds\xa0Heart Failure Success Series was created in memory of Dr. David Taylor. We thank our partners at the Heart Failure Society of America\xa0which is a multidisciplinary organization working to improve and expand heart failure care through collaboration, education, research, innovation, and advocacy. Its members include physicians, scientists, nurses, nurse practitioners, and pharmacists. Learn more at\xa0hfsa.org.